Blog
RSS FeedPosted by Michael Wonder on 22 Jan 2019
Celgene, sold for $74 billion, leaves a legacy of chutzpah in science and drug pricing
22 January 2019 - Nina Kjellson was just two years out of college, working as a research associate at Oracle ...
Posted by Michael Wonder on 14 Jan 2019
A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.
13 January 2019 - A one-time treatment for a devastating rare disease could be paid for with an instalment plan as ...
Posted by Michael Wonder on 09 Jan 2019
Biotech proposes paying for pricey drugs by instalment
8 January 2019 - Bluebird Bio develops plan to sell gene-replacement therapy with annual payments contingent on continued effectiveness. ...
Posted by Michael Wonder on 22 Dec 2018
Dealing with drug pricing: not just one solution
22 December 2018 - On 11 December, US FDA Commissioner Scott Gottlieb announced a set of rules that would change the ...
Posted by Michael Wonder on 19 Dec 2018
More lawsuits = higher drug prices
18 December 2018 - The FDA pulls an Obama rule that was a trial-lawyer special. ...
Posted by Michael Wonder on 18 Dec 2018
Warren unveils bill to lower drug prices by letting government manufacture them
18 December 2018 - Senator Elizabeth Warren has unveiled a bill aimed at lowering drug prices by allowing the government ...
Posted by Michael Wonder on 16 Dec 2018
A drug that was once inexpensive gets a new price tag: $375,000
13 December 2018 - An old, formerly inexpensive drug called Firdapse was just slapped with a steep new price tag: ...
Posted by Michael Wonder on 13 Dec 2018
Authorized generic for Evzio (naloxone hydrochloride injection) to be available at a reduced list price of $178
12 December 2018 - Product will be available in 2019. ...
Posted by Michael Wonder on 10 Dec 2018
Investigation of generic ‘cartel’ expands to 300 drugs
9 December 2018 - Executives at more than a dozen generic drug companies had a form of shorthand to describe ...
Posted by Michael Wonder on 09 Dec 2018
Medical device price differentials in the U.S. and Europe – rethinking price regulation?
7 December 2018 - Recently, there has been a robust discussion of an October Trump administration proposal that Medicare pay for ...
Posted by Michael Wonder on 05 Dec 2018
Generic drug prices ‘strongly predictive’ of shortages, study finds
4 December 2018 - How a generic drug is priced may be the difference between whether it experiences a shortage ...
Posted by Michael Wonder on 01 Dec 2018
‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients
30 November 2018 - Vickie Moored can walk again. Her words don’t slur, her vision isn’t blurred, and she no ...
Posted by Michael Wonder on 27 Nov 2018
FDA promised a ‘lower-cost option’ to EpiPen, but the price isn’t any lower
27 November 2018 - Teva's alternative to Mylan's authorised generic EpiPen is no cheaper. ...
Posted by Michael Wonder on 27 Nov 2018
Loxo and Bayer's amazing drug has an expensive price
26 November 2018 - A little more than a year ago, I wrote the story of a cancer drug developed by ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...